Back to Search
JOYCE O'SHAUGHNESSY, MD
MD
Medical Oncology Physician
NPI: 1790727709IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K3366(TX)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1982
Research & Publications (20)
RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.
PMID 18757267·Clin Breast Cancer·2008
8-other
Management of febrile neutropenia and cardiac toxicity in the adjuvant treatment of breast cancer.
PMID 18282366·Clin Breast Cancer·2007
6-review
Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.
PMID 16764743·Clin Breast Cancer·2006
6-review
Phase II trial of weekly docetaxel/ gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer.
PMID 16595033·Clin Breast Cancer·2006
3-trial
Extending survival with chemotherapy in metastatic breast cancer.
PMID 16368868·Oncologist·2005
6-review
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
PMID 15748464·Clin Breast Cancer·2005
3-trial
Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
PMID 15245619·Clin Breast Cancer·2004
3-trial
New perspectives with antimetabolites in the management of breast cancer.
PMID 14754465·Clin Breast Cancer·2004
8-other
Chemotherapy-related cognitive dysfunction in breast cancer.
PMID 14702917·Semin Oncol Nurs·2003
6-review
Chemotherapy-induced cognitive dysfunction: a clearer picture.
PMID 14705598·Clin Breast Cancer·2003
6-review
Pegylated liposomal doxorubicin in the treatment of breast cancer.
PMID 14715106·Clin Breast Cancer·2003
6-review
Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
PMID 14768400·Oncology (Williston Park)·2003
6-review
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.
PMID 12065558·J Clin Oncol·2002
3-trial
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
PMID 11839647·Clin Cancer Res·2002
8-other
Capecitabine and docetaxel in advanced breast cancer: analyses of a phase III comparative trial.
PMID 12435175·Oncology (Williston Park)·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3410 WORTH ST STE 400
DALLAS, TX 75246 - Phone
- (214) 370-1000
Quick Facts
- NPI
- 1790727709
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile